<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02438371</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-15-0134</org_study_id>
    <nct_id>NCT02438371</nct_id>
  </id_info>
  <brief_title>Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor</brief_title>
  <official_title>Nifedipine Alone or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor: An Open Label, Randomized Comparative Effectiveness Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tocolytic agents are used for the treatment of preterm labor. It is unclear whether&#xD;
      combination treatments of two tocolytic agents are more effective in stopping preterm labor&#xD;
      compared to one. Therefore, the investigators propose a comparative effective trial of&#xD;
      nifedipine plus indomethacin vs. nifedipine alone for the treatment of preterm labor&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators current treatment for preterm labor has not been shown to be effective in&#xD;
      prolonging pregnancy sufficiently to improve neonatal outcomes and other treatment strategies&#xD;
      are needed. Multiple examples demonstrate that multi-agent treatments are routine clinical&#xD;
      practice in other fields of medicine including chemotherapeutics for cancer,&#xD;
      multi-therapeutics for myocardial infarction and broad spectrum antibiotics for pneumonia. At&#xD;
      this time, it is unclear if a combination of tocolytic medications for preterm labor is more&#xD;
      advantageous for women. If pregnancy is prolonged with combined tocolytic therapy, this could&#xD;
      directly influence the treatment of preterm labor and potentially improve neonatal outcomes.&#xD;
      There currently are no trials of combination regimens using widely used tocolytic agents,&#xD;
      such as nifedipine and indomethacin. Thus, we propose a comparative effective trial of&#xD;
      nifedipine plus indomethacin vs. nifedipine alone for the treatment of preterm labor&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study halted due to slow recruitment&#xD;
  </why_stopped>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">October 10, 2019</completion_date>
  <primary_completion_date type="Actual">October 10, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of women who remain pregnant</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of pregnancy</measure>
    <time_frame>up to 9 months</time_frame>
    <description>Length of time from tocolytic initiation to the time of delivery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Preterm Labor</condition>
  <arm_group>
    <arm_group_label>Single</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>They will receive nifedipine for the treatment of preterm labor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combination</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>They will receive nifedipine plus indomethacin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nifedipine</intervention_name>
    <description>Nifedipine will be given for the treatment of preterm labor</description>
    <arm_group_label>Combination</arm_group_label>
    <arm_group_label>Single</arm_group_label>
    <other_name>Procardia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indomethacin</intervention_name>
    <description>Nifedipine and indomethacin will be give for the treatment of pretermlabor</description>
    <arm_group_label>Combination</arm_group_label>
    <other_name>Indomethacin and Nifedipine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  We will include pregnant women between 220/7 to 316/7 weeks gestation who present with&#xD;
             regular uterine contractions defined as at least one contraction every 10 minutes for&#xD;
             30 minutes with at least one of the following:&#xD;
&#xD;
          -  cervical change or&#xD;
&#xD;
          -  2 cm dilated or&#xD;
&#xD;
          -  positive fetal fibronectin or&#xD;
&#xD;
          -  transvaginal cervical length &lt;2.5 cm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  We will exclude pregnant women with any contraindication to tocolysis:&#xD;
&#xD;
          -  clinical chorioamnionitis (defined as a temperature of &gt;100.4 F and any of the&#xD;
             following: fundal tenderness, maternal tachycardia, fetal tachycardia or purulent&#xD;
             vaginal discharge)&#xD;
&#xD;
          -  non reassuring fetal heart tones&#xD;
&#xD;
          -  suspected placental abruption&#xD;
&#xD;
          -  preterm premature rupture of membranes&#xD;
&#xD;
          -  prior tocolytic treatment during their pregnancy&#xD;
&#xD;
          -  known adverse effect to indomethacin or nifedipine&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Hutchinson, M.S.</last_name>
    <role>Study Director</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Memorial Hermann Hospital Texas Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>May 5, 2015</study_first_submitted>
  <study_first_submitted_qc>May 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2015</study_first_posted>
  <disposition_first_submitted>October 8, 2020</disposition_first_submitted>
  <disposition_first_submitted_qc>October 8, 2020</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">October 19, 2020</disposition_first_posted>
  <last_update_submitted>October 8, 2020</last_update_submitted>
  <last_update_submitted_qc>October 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Nanaama Ankumah Bentum</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>pregnancy</keyword>
  <keyword>preterm labor</keyword>
  <keyword>tocolysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Indomethacin</mesh_term>
    <mesh_term>Nifedipine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>October 25, 2021</submitted>
  </pending_results>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

